Earnings Per Share (EPS) Summary (Annual)
According to NextCure's latest annual financial reports, the company has an earnings per share (EPS) of $-1.99 and a diluted EPS of $-1.99. The EPS indicates the portion of a company's profit allocated to each outstanding share of common stock, serving as an indicator of a company's profitability.
The company's EPS growth rate stands at 11.56%, and the diluted EPS growth rate is 11.56%. These metrics reflect the annual growth rate of earnings per share and diluted earnings per share over the specified period.
EPS
$-1.99
Diluted EPS
$-1.99
EPS Growth
11.56%
NextCure Historical EPS
NextCure Historical EPS Growth
EPS History
The table below shows the EPS for each year, with the latest data available for the last fiscal year 2024.
| Year | EPS | Change |
|---|---|---|
| 2024 | $-1.99 | 11.56% |
| 2023 | $-2.25 | 10.00% |
| 2022 | $-2.5 | 0.40% |
| 2021 | $-2.51 | -107.44% |
| 2020 | $-1.21 | 43.72% |
| 2019 | $-2.15 | 5.29% |
| 2018 | $-2.27 | -47.40% |
| 2017 | $-1.54 | 0.00% |
Related Metrics
Explore detailed financial metrics and analysis for NXTC.